flâneur

Interleukin-6 Blockade as Rescue Therapy in Autoimmune Encephalitis - PMC

ncbi.nlm.nih.gov · 2,021 words · saved by 1 readers

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now. Brain Autoimmunity Group, Institute for Neuroscience and Muscle Research, the Children’s Hospital at Westmead, University of Sydney, Sydney, Australia Autoimmune encephalitis (AE) is an expanding group of inflammatory brain conditions defined by the presence of autoantibodies against cell-surface proteins such as neuronal receptors or synaptic proteins [1]. AE is important to suspect and diagnose, as early immune therapy appears to improve outcomes [2]. Wi

editorial Neurotherapeutics . 2016 Aug 16;13(4):821–823. doi: 10.1007/s13311-016-0471-1 Interleukin-6 Blockade as Rescue Therapy in Autoimmune Encephalitis Russell C Dale Russell C Dale 1 Brain Autoimmunity Group, Institute for Neuroscience and Muscle Research, the Children’s Hospital at Westmead, University of Sydney, Sydney, Australia Find articles by Russell C Dale 1, ✉ Author information Article notes Copyright and License information 1 Brain Autoimmunity Group, Institute for Neuroscience and Muscle Research, the Children’s Hospital at Westmead, University of Sydney, Sydney, Australia ✉ Co

saved by

related reading